Publications by authors named "Anna Pous"

Claim this Profile
I
Immune-based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2- breast cancer.
Eudald Felip, Edurne Garcia-Vidal, Sara Cabrero-de Las Heras, Adrià Bernat-Peguera, Beatriz Cirauqui, Anna Pous

Clin Transl Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort Study.
Helena Pla, Bartomeu Fullana, Anna Esteve, Roser Fort-Culillas, Angelica Ferrando-Díez, Anna Pous

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Iris Teruel, Eva Castellà, Sabela Recalde, Gemma Viñas, Anna Petit, Anna Pous

Int J Mol Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer.
Anna Pous, Adrià Bernat-Peguera, Assumpció López-Paradís, Beatriz Cirauqui, Vanesa Quiroga

Ther Adv Med Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.
Lucía Gutiérrez-Chamorro, Eudald Felip, Eva Castellà, Vanessa Quiroga, Ifeanyi Jude Ezeonwumelu, Anna Pous

Cell Oncol (Dordr)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies.
Anna Pous, Lucía Notario, Cinta Hierro, Laura Layos, Cristina Bugés

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study.
Ainhoa Hernandez, Marc Boigues, Eudald Felip, Marc Cucurull, Lucia Notario, Anna Pous

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
Alessio Cortellini, Alessandra Gennari, Fanny Pommeret, Grisma Patel, Thomas Newsom-Davis, Anna Pous

J Natl Cancer Inst· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer.
Angelica Ferrando-Díez, Eudald Felip, Anna Pous, Milana Bergamino Sirven, Mireia Margelí

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.

JAMA Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
David J Pinato, Josep Tabernero, Mark Bower, Lorenza Scotti, Meera Patel, Anna Pous

Lancet Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen.
Anna Pous, Cristina Izquierdo, Marc Cucurull, Silvia Sánchez, Clara Lezcano

Transl Lung Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced willingness to invest effort in schizophrenia with high negative symptoms regardless of reward stimulus presentation and reward value.
Daniel Bergé, Clara Pretus, Xavier Guell, Anna Pous, Aaron Arcos

Compr Psychiatry· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis